| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |